Abstract

The Problem of Drug Diversion

Author(s): Burke John J

Issue: Jan/Feb 2002 - Compounding for Pain Management and Dental Medicine

Page(s): 11-12

Download in electronic PDF format for $75
  • The Problem of Drug Diversion Page 1
  • The Problem of Drug Diversion Page 2

Abstract

This discussion, by a commander of the Warren County Drug Task Force in Lebanon, OH, and the vice president of the National Association of Drug Diversion Investigators, covers the most frequently abused pharmaceuticals in the United States and avenues of health-care fraud. The author concludes that reducing prescription drug abuse is the responsibility of the physician, pharmacist and law enforcement officials and that these professionals must cooperate to identify and eliminate such addiction.

Related Keywords

  • Drug diversion

Related Categories

  • BUSINESS
  • LEGAL
  • DEA

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2002
Pg. 11-12
The Problem of Drug Diversion
Author(s): Burke John J
Jan/Feb 2002
Pg. 13-15
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective
Author(s): Vail Jane
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
May/Jun 2016
Pg. 202-206
Does Your Drug Expertise Include Clinical Pharmaceutics?
Author(s): Newton David W
Jul/Aug 2012
Pg. 294-298
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Author(s): Allen Loyd V Jr, Williams LaVonn A
Mar/Apr 2011
Pg. 92
PreScription: Discontinued Drugs and Drug Shortages
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 298-301
The Role of Compounding Pharmacists During Drug Shortages
Author(s): Ofei Kelvin
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Jul/Aug 2012
Pg. 350-351
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Author(s): Allen Loyd V Jr, Williams LaVonn A
Jul/Aug 2002
Pg. 271-273
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Author(s): Kramer Mark A, Grilley Bambi J
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
May/Jun 2006
Pg. 175-183
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Author(s): Stephenson Kenna, Jones William, Stephenson Douglas M M
Jul/Aug 2018
Pg. 268
PreScription: Factors Related to Drug Waste and Pharmacy Solutions
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 379-380
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Author(s): Blankenship Cynthia E
Sep/Oct 2015
Pg. 377-380
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake